CD52 and pure red-cell aplasia: Besides, such immunosuppressive agents, like purine analogue (e.g. fludarabine in combination with dexamethasone) have had impressive response rate and Alemtuzumab (Campath), as a monoclonal antibody against CD52 is served as an effective therapy for LGL leukemia mostly with PRCA [31].